Cargando…
Response to Comment on Goldfine et al. Targeting Inflammation Using Salsalate in Patients With Type 2 Diabetes: Effects on Flow-Mediated Dilation (TINSAL-FMD). Diabetes Care 2013;36:4132–4139
Autores principales: | Goldfine, Allison B., Jablonski, Kathleen A., Shoelson, Steven E., Creager, Mark A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Diabetes Association
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4876756/ https://www.ncbi.nlm.nih.gov/pubmed/24757239 http://dx.doi.org/10.2337/dc14-0222 |
Ejemplares similares
-
Comment on Goldfine et al. Targeting Inflammation Using Salsalate in Patients With Type 2 Diabetes: Effects on Flow-Mediated Dilation (TINSAL-FMD). Diabetes Care 2013;36:4132–4139
por: Pierce, Gary L., et al.
Publicado: (2014) -
Targeting Inflammation Using Salsalate in Patients With Type 2 Diabetes: Effects on Flow-Mediated Dilation (TINSAL-FMD)
por: Goldfine, Allison B., et al.
Publicado: (2013) -
The Impact of Salsalate Treatment on Serum Levels of Advanced Glycation End Products in Type 2 Diabetes
por: Barzilay, Joshua I., et al.
Publicado: (2014) -
Comment on: Bernstein. Reducing Foot Wounds in Diabetes. Diabetes Care 2013;36:e48
por: Morbach, Stephan, et al.
Publicado: (2013) -
Comment on Knowler et al. Preventing Diabetes in American Indian Communities. Diabetes Care 2013;36:1820–1822
por: Jiang, Luohua, et al.
Publicado: (2014)